Refractory Anaphylaxis Needing Emergency Intubation Supported by Expert Opinion and Published Guidelines: Could We Use Off-Label Drugs to Avoid It?
- PMID: 35485592
- DOI: 10.1097/CCM.0000000000005399
Refractory Anaphylaxis Needing Emergency Intubation Supported by Expert Opinion and Published Guidelines: Could We Use Off-Label Drugs to Avoid It?
Conflict of interest statement
The authors have disclosed that they do not have any potential conflicts of interest.
Comment in
-
The author replies.Crit Care Med. 2022 May 1;50(5):e499-e500. doi: 10.1097/CCM.0000000000005482. Epub 2022 Apr 11. Crit Care Med. 2022. PMID: 35485593 No abstract available.
Comment on
-
Critical Care Management of the Patient With Anaphylaxis: A Concise Definitive Review.Crit Care Med. 2021 May 1;49(5):838-857. doi: 10.1097/CCM.0000000000004893. Crit Care Med. 2021. PMID: 33653974
References
-
- Krishnaswamy G: Critical care management of the patient with anaphylaxis: A concise definitive review. Crit Care Med. 2021; 49:838–857
-
- Krogh Nielsen T, Bygum A, Rye Rasmussen E: Life-threatening angio-oedema after the first dose of an ACE inhibitor-not an anaphylactic reaction. BMJ Case Rep. 2016; 2016:bcr2016214364
-
- Tai S, Mascaro M, Goldstein NA: Angioedema: A review of 367 episodes presenting to three tertiary care hospitals. Ann Otol Rhinol Laryngol. 2010; 119:836–841
-
- Ostenfeld S, Bygum A, Rasmussen ER: Life-threatening ACE inhibitor-induced angio-oedema successfully treated with icatibant: A bradykinin receptor antagonist. BMJ Case Rep. 2015; 2015:bcr2015212891
-
- Piotrowicz-Wójcik K, Porebski G: Life-threatening laryngeal attacks in hereditary angioedema patients. Otolaryngol Pol. 2020; 74:1–5
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
